CADL - Candel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

CADL is currently covered by 5 analysts with an average price target of $16. This is a potential upside of $7.61 (90.7%) from yesterday's end of day stock price of $8.39.

Candel Therapeutics's activity chart (see below) currently has 17 price targets and 29 ratings on display. The stock rating distribution of CADL is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 16.67% of the time, taking 46.67 days on average.

Highest price target for CADL is $23, Lowest price target is $13, average price target is $16.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD. First documented stock forecast 23-Aug-2021.

Best performing analysts who are covering CADL - Candel Therapeutics:

Alec Stranahan Ilya Zubkov Sudan Loganathan Andres Maldonado

Currently out of the existing stock ratings of CADL, 9 are a BUY (75%), 3 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Feb-2025

$13

$4.61 (54.95%)

Hold Since 17-May-2026

$18

$9.61 (114.54%)

$12

1 months 25 days ago
(20-Sep-2026)

3/5 (60%)

$6.79 (60.57%)

83

Buy Since 28-Sep-2025

$23

$14.61 (174.14%)

$23

3 months 2 days ago
(12-Aug-2026)

0/5 (0%)

$11.2 (94.92%)

Buy Since 20-Feb-2025

$22

7 months 28 days ago
(18-Mar-2026)

0/2 (0%)

$17.33 (371.09%)

Buy Since 28-Oct-2025

$15

$5.21 (53.22%)

$15

11 months 7 days ago
(08-Dec-2025)

0/2 (0%)

$9.55 (175.23%)

Show more analysts

Please expand the browser size to see the chart

What is CADL (Candel Therapeutics) average time for price targets to be met?

On average it took 47 days for the stock forecasts to be reached, with an average price target met ratio of 16.67%.

Which analyst most recently updated their price target on CADL (Candel Therapeutics)?

John Newman

Which analyst has the most public recommendations on CADL (Candel Therapeutics)?

John Newman works at CANACCORD and has 3 price targets and 4 ratings on CADL

Which analyst is the currently most bullish on CADL (Candel Therapeutics)?

Chris Howerton with the highest potential upside of $17.17

Which analyst is the currently most reserved on CADL (Candel Therapeutics)?

Evan Seigerman with the lowest potential downside of -$5.39
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?